Title: Interferons limit autoantigen-specific CD8(+) T-cell expansion in the non-obese diabetic mouse
Authors: Jhala, G
Krishnamurthy, B
Brodnicki, TC
Ge, TT
Akazawa, S
Selck, C
Trivedi, PM
Pappas, EG
Mackin, L
Principe, N
Bremaud, E
De George, DJ
Boon, L
Smyth, I
Chee, J
Kay, TWH
Thomas, HE
Issue Year: 2022
Publisher CELL PRESS
Series CELL REPORTS:
Abstract Interferon gamma (IFN gamma) is a proinflammatory cytokine implicated in autoimmune diseases. However, deficiency or neutralization of IFN gamma is ineffective in reducing disease. We characterize islet antigen-specific T cells in non-obese diabetic (NOD) mice lacking all three IFN receptor genes. Diabetes is minimally affected, but at 125 days of age, antigen-specific CD8(+) T cells, quantified using major histocompatibility complex class I tetramers, are present in 10-fold greater numbers in Ifngr-mutant NOD mice. T cells from ifngr-mutant mice have increased proliferative responses to interleukin-2 (IL-2). They also have reduced phosphorylated STAT1 and its target gene, suppressor of cytokine signaling 1 (SOCS-1). IFN gamma controls the expansion of antigen-specific CD8(+) T cells by mechanisms which include increased SOCS-1 expression that regulates IL-2 signaling. The expanded CD8(+) T cells are likely to contribute to normal diabetes progression despite reduced inflammation in Ifngr-mutant mice.
URI: https://publications.svi.edu.au/publications/8739
Other Identifiers 10.1016/j.celrep.2022.110747
Publication type Article